Clinical Trial Update: Anti-TNFα Therapy for Improving Pregnancy Rates in Endometriosis Patients With Failed ICSI [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating anti-TNFα therapy to improve pregnancy rates in endometriosis patients after failed ICSI. The study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Snippet

Sponsor: Benha University | Conditions: Endometriosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING